TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,733,000 | -82.5% | 452,375 | -80.3% | 0.44% | -84.4% |
| Q2 2016 | $9,888,000 | -41.5% | 2,299,529 | -37.1% | 2.83% | -53.4% |
| Q1 2016 | $16,914,000 | -13.1% | 3,653,200 | +88.3% | 6.07% | -25.7% |
| Q4 2015 | $19,458,000 | +132.9% | 1,940,000 | +73.2% | 8.16% | +147.0% |
| Q3 2015 | $8,355,000 | – | 1,120,000 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |